ArticleNutrients2020
Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.
Full text read
In one paragraph
Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Effects of Ranolazine on Vascular Adrenergic Receptors in Rabbit Aorta.International journal of medical sciences · 2026Article
- Tea Polyphenol Modulates Mitochondria-Associated Endoplasmic Reticulum Membrane of Hippocampal Neurons Targeting Grp75 to Ameliorate Memory Impairment in the Aged T2DM Rats.Food science & nutrition · 2025Article
- Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model.BMC pharmacology & toxicology · 2025Article
- Trelagliptin Ameliorates Memory Decline in Diabetic Rats through the AMPK/AKT/GSK-3β Pathway in the Cerebral Cortex.ACS omega · 2025Article
- Unraveling the pharmacological and therapeutic potential of Ranolazine beyond antianginal drug use: a new insight.Experimental biology and medicine (Maywood, N.J.) · 2025Review
- A pathophysiological intersection between metabolic biomarkers and memory: a longitudinal study in the STZ-induced diabetic mouse model.Frontiers in physiology · 2025Article
- Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes.Burns & trauma · 2025Article
- Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence.Cardiovascular & hematological disorders drug targets · 2025Review
- Effects of GS-967, GS-6615 and ranolazine on the responses of the rabbit aorta to adrenergic nerve stimulation.Frontiers in physiology · 2025Article
- Association between ranolazine therapy and cognitive decline in elderly patients with ischemic heart disease.Frontiers in pharmacology · 2025Article
- Revealing the biological features of the axolotl pancreas as a new research model.Frontiers in cell and developmental biology · 2025Article
- The Promising Potency of Sodium-Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients.Biomedicines · 2024Review
- Alleviation of taurine on liver injury of type 2 diabetic rats by improving antioxidant and anti-inflammatory capacity.Heliyon · 2024Article
- Rodent models of AKI and AKI-CKD transition: an update in 2024.American journal of physiology. Renal physiology · 2024Review
- The Alteration of Proteomic Profiles in Hippocampus of Type 2 Diabetic Mice Associated With Cognitive Impairment.Bioinformatics and biology insights · 2024Article
- MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism.iScience · 2023Article
- Article
- Improvement of Vascular Insulin Sensitivity by Ranolazine.International journal of molecular sciences · 2023Article
- Progranulin Protects against Hyperglycemia-Induced Neuronal Dysfunction through GSK3β Signaling.Cells · 2023Article
- Protective effects of swimming exercises and metformin on cardiac and aortic damage caused by a high-fat diet in obese rats with type 2 diabetes, by regulating the Bcl2/Bax signaling pathway.Turkish journal of medical sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Velia CassanoDepartment of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, Italy.
Antonio LeoScience of Health Department, Magna Græcia University, 88100 Catanzaro, Italy.
Martina TallaricoScience of Health Department, Magna Græcia University, 88100 Catanzaro, Italy.
Valentina NesciScience of Health Department, Magna Græcia University, 88100 Catanzaro, Italy.
Antonio CimellaroPugliese-Ciaccio, Hospital, Internal Medicine Unit, 88100 Catanzaro, Italy.
Teresa Vanessa FiorentinoDepartment of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, Italy.
Rita CitraroScience of Health Department, Magna Græcia University, 88100 Catanzaro, Italy.
Marta Letizia HribalDepartment of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, Italy.
Giovambattista De SarroScience of Health Department, Magna Græcia University, 88100 Catanzaro, Italy.
Francesco PerticoneDepartment of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, Italy.
Giorgio SestiDepartment of Clinical and Molecular Medicine, University of Rome-Sapienza, 00189 Rome, Italy.
Emilio RussoScience of Health Department, Magna Græcia University, 88100 Catanzaro, Italy.
Angela SciacquaDepartment of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, Italy.
Funding
Italian Ministry of Education 2015MPESJS_006
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsBehavior, AnimalBlood GlucoseCognitionDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diet, High-FatGlucose Tolerance TestHypoglycemic AgentsMaze LearningMetforminRanolazineRatsRats, WistarStreptozocinBlood GlucoseHypoglycemic AgentsMetforminRanolazineStreptozocinAlzheimer’s diseaseCognitive impairmentMetforminRanolazineType 2 DiabetesType 3 diabetes
Identifiers
What OpenQuestion holds
Textfull text, public
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.